Share Price and Basic Stock Data
Last Updated: October 18, 2025, 6:26 pm
PEG Ratio | 0.92 |
---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Refex Industries Ltd operates in the industrial gases sector, with a current market capitalization of ₹4,628 Cr and a stock price of ₹358. The company has shown significant revenue growth, with sales recorded at ₹1,629 Cr for FY 2023, up from ₹444 Cr in FY 2022. This impressive increase reflects a robust business model and strategic market positioning. Sales for the quarter ending June 2024 stood at ₹585 Cr, indicating a healthy quarterly performance. However, quarterly sales fluctuated, with a peak of ₹630 Cr in March 2023 and a decline to ₹350 Cr in September 2023. The trailing twelve months (TTM) sales are reported at ₹2,204 Cr, suggesting ongoing demand for Refex’s products. The company’s operating profit margin (OPM) averaged around 11% for FY 2025, showcasing effective cost management. Overall, Refex’s revenue trajectory demonstrates resilience despite market volatility, suggesting a strong foothold in the industrial gases industry.
Profitability and Efficiency Metrics
Refex Industries Ltd recorded a net profit of ₹189 Cr for FY 2025, up from ₹116 Cr in FY 2023, indicating a solid growth trajectory in profitability. The company’s earnings per share (EPS) stood at ₹12.93, reflecting improved shareholder returns. The return on equity (ROE) is reported at 22%, and the return on capital employed (ROCE) at 25.3%, both of which are robust metrics indicating effective capital utilization. The interest coverage ratio (ICR) was recorded at 9.39 times, suggesting strong earnings relative to interest obligations, which is favorable for financial stability. However, the cash conversion cycle (CCC) remains at 66 days, which could indicate potential inefficiencies in inventory or receivables management. The company has maintained a consistent operating profit margin, averaging around 11%, although it experienced slight fluctuations in quarterly performance, with margins ranging from 8% to 13%. This stability in profitability metrics underscores Refex’s operational efficacy.
Balance Sheet Strength and Financial Ratios
As of FY 2025, Refex Industries Ltd reported total reserves of ₹1,224 Cr against borrowings of ₹158 Cr, highlighting a strong balance sheet with a low debt-to-equity ratio of 0.14. This indicates that the company is not overly leveraged, providing a solid foundation for future growth. The current ratio stood at 3.49, and the quick ratio at 3.47, both reflecting excellent liquidity positions, ensuring that Refex can meet its short-term obligations comfortably. Additionally, the company’s price-to-book value (P/BV) ratio is at 4.02x, which may suggest that the stock is trading at a premium relative to its book value, reflecting market confidence. However, the return on assets (ROA) is relatively lower at 8.82%, which may indicate room for improvement in asset efficiency. Overall, Refex’s financial ratios demonstrate a well-managed balance sheet with a focus on maintaining liquidity and minimizing debt.
Shareholding Pattern and Investor Confidence
Refex Industries Ltd’s shareholding pattern indicates a stable promoter holding of 53.33%, which reflects a strong commitment from the founding shareholders. Foreign institutional investors (FIIs) have increased their stake to 1.86%, while domestic institutional investors (DIIs) hold a modest 0.16%. The public holding accounts for 44.65%, with the total number of shareholders rising to 85,429, indicating growing investor interest. The increase in shareholder count over recent quarters suggests enhanced market participation and confidence in the company’s growth prospects. Notably, promoter ownership has shown slight fluctuations but has generally remained above 50%, which is a positive sign of governance and control. However, the low institutional investment may signal a lack of broader institutional confidence, which could be a potential risk if not addressed. The overall shareholding trend suggests a healthy investor base with a strong promoter commitment.
Outlook, Risks, and Final Insight
If margins sustain around current levels and the company can manage operational efficiencies to reduce the cash conversion cycle, Refex Industries Ltd could continue its growth trajectory. The low debt levels and high liquidity ratios provide a cushion against market volatility, allowing for potential reinvestment in growth initiatives. However, risks remain, particularly in managing fluctuating sales and expenses, which could impact profitability if not addressed. Additionally, the reliance on domestic markets poses a risk if economic conditions shift. Strengthening institutional investor participation could enhance market credibility and stability. Overall, while the company shows strong financial health and operational efficiency, it must navigate market dynamics carefully to sustain its growth and profitability in the competitive industrial gases sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Refex Industries Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Gagan Gases Ltd | 11.9 Cr. | 26.4 | 35.8/17.6 | 56.8 | 7.33 | 0.00 % | 10.6 % | 8.49 % | 10.0 |
Bhagawati Oxygen Ltd | 10.3 Cr. | 44.6 | 72.3/36.3 | 17.2 | 0.00 % | 6.68 % | 10.6 % | 10.0 | |
Refex Industries Ltd | 4,751 Cr. | 347 | 575/334 | 25.4 | 96.8 | 0.14 % | 25.3 % | 22.0 % | 2.00 |
Linde India Ltd | 52,477 Cr. | 6,154 | 8,470/5,202 | 119 | 443 | 0.07 % | 16.9 % | 12.3 % | 10.0 |
Industry Average | 28,614.00 Cr | 1,643.00 | 67.07 | 141.08 | 0.05% | 14.87% | 13.35% | 8.00 |
Quarterly Result
Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 265 | 353 | 380 | 630 | 381 | 350 | 302 | 337 | 585 | 520 | 708 | 611 | 365 |
Expenses | 243 | 317 | 341 | 557 | 345 | 315 | 268 | 294 | 533 | 472 | 655 | 548 | 325 |
Operating Profit | 22 | 37 | 40 | 74 | 37 | 35 | 34 | 44 | 52 | 48 | 53 | 64 | 40 |
OPM % | 8% | 10% | 10% | 12% | 10% | 10% | 11% | 13% | 9% | 9% | 8% | 10% | 11% |
Other Income | 2 | 2 | 1 | 2 | 2 | 5 | 3 | 8 | 2 | 8 | 25 | 16 | 11 |
Interest | 4 | 3 | 4 | 6 | 6 | 6 | 7 | 7 | 4 | 4 | 5 | 5 | 6 |
Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 4 |
Profit before tax | 19 | 34 | 36 | 68 | 30 | 32 | 27 | 43 | 48 | 50 | 71 | 72 | 41 |
Tax % | 27% | 26% | 26% | 25% | 26% | 27% | 28% | 16% | 25% | 25% | 17% | 21% | 20% |
Net Profit | 14 | 25 | 26 | 51 | 22 | 23 | 20 | 36 | 36 | 37 | 59 | 57 | 33 |
EPS in Rs | 1.31 | 2.42 | 2.37 | 4.59 | 1.99 | 2.12 | 1.79 | 3.09 | 3.11 | 3.09 | 4.58 | 4.42 | 2.55 |
Last Updated: August 20, 2025, 4:30 am
Below is a detailed analysis of the quarterly data for Refex Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 365.00 Cr.. The value appears to be declining and may need further review. It has decreased from 611.00 Cr. (Mar 2025) to 365.00 Cr., marking a decrease of 246.00 Cr..
- For Expenses, as of Jun 2025, the value is 325.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 548.00 Cr. (Mar 2025) to 325.00 Cr., marking a decrease of 223.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 64.00 Cr. (Mar 2025) to 40.00 Cr., marking a decrease of 24.00 Cr..
- For OPM %, as of Jun 2025, the value is 11.00%. The value appears strong and on an upward trend. It has increased from 10.00% (Mar 2025) to 11.00%, marking an increase of 1.00%.
- For Other Income, as of Jun 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Mar 2025) to 11.00 Cr., marking a decrease of 5.00 Cr..
- For Interest, as of Jun 2025, the value is 6.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 4.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.00 Cr. (Mar 2025) to 4.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 72.00 Cr. (Mar 2025) to 41.00 Cr., marking a decrease of 31.00 Cr..
- For Tax %, as of Jun 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 21.00% (Mar 2025) to 20.00%, marking a decrease of 1.00%.
- For Net Profit, as of Jun 2025, the value is 33.00 Cr.. The value appears to be declining and may need further review. It has decreased from 57.00 Cr. (Mar 2025) to 33.00 Cr., marking a decrease of 24.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.55. The value appears to be declining and may need further review. It has decreased from 4.42 (Mar 2025) to 2.55, marking a decrease of 1.87.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:34 am
Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 25 | 85 | 78 | 38 | 77 | 461 | 661 | 633 | 444 | 1,629 | 1,371 | 2,430 | 2,204 |
Expenses | 22 | 79 | 75 | 36 | 75 | 433 | 609 | 565 | 383 | 1,454 | 1,222 | 2,214 | 2,000 |
Operating Profit | 2 | 6 | 3 | 2 | 2 | 28 | 51 | 68 | 61 | 175 | 149 | 216 | 204 |
OPM % | 10% | 7% | 3% | 6% | 2% | 6% | 8% | 11% | 14% | 11% | 11% | 9% | 9% |
Other Income | 3 | -0 | 0 | 2 | 2 | 2 | -1 | 4 | 18 | 8 | 18 | 52 | 61 |
Interest | 2 | 0 | 1 | 3 | 1 | 0 | 1 | 9 | 13 | 19 | 26 | 18 | 19 |
Depreciation | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 5 | 6 | 7 | 9 | 11 | 12 |
Profit before tax | 1 | 3 | 0 | 1 | 2 | 29 | 48 | 58 | 61 | 156 | 132 | 241 | 234 |
Tax % | -0% | -0% | -1,613% | 13% | 46% | -10% | 31% | 29% | 26% | 26% | 23% | 21% | |
Net Profit | 1 | 3 | 5 | 0 | 1 | 32 | 33 | 41 | 45 | 116 | 101 | 189 | 186 |
EPS in Rs | 0.11 | 0.29 | 0.51 | 0.04 | 0.09 | 3.01 | 3.16 | 3.90 | 4.32 | 10.50 | 8.73 | 14.66 | 14.64 |
Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | 8% | -0% | 4% | 6% | -0% |
YoY Net Profit Growth
Year | 2014-2015 | 2015-2016 | 2016-2017 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | 200.00% | 66.67% | -100.00% | 3100.00% | 3.12% | 24.24% | 9.76% | 157.78% | -12.93% | 87.13% |
Change in YoY Net Profit Growth (%) | 0.00% | -133.33% | -166.67% | 3200.00% | -3096.88% | 21.12% | -14.49% | 148.02% | -170.71% | 100.06% |
Refex Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 40% |
5 Years: | 30% |
3 Years: | 76% |
TTM: | 40% |
Compounded Profit Growth | |
---|---|
10 Years: | 51% |
5 Years: | 39% |
3 Years: | 75% |
TTM: | 63% |
Stock Price CAGR | |
---|---|
10 Years: | 72% |
5 Years: | 109% |
3 Years: | 133% |
1 Year: | -8% |
Return on Equity | |
---|---|
10 Years: | 30% |
5 Years: | 27% |
3 Years: | 27% |
Last Year: | 22% |
Last Updated: September 5, 2025, 1:00 pm
Balance Sheet
Last Updated: May 13, 2025, 2:50 pm
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 21 | 21 | 22 | 23 | 26 |
Reserves | -14 | -11 | -6 | -5 | -4 | 27 | 60 | 119 | 163 | 292 | 450 | 1,224 |
Borrowings | 11 | 9 | 37 | 35 | 41 | 0 | 9 | 74 | 85 | 149 | 161 | 158 |
Other Liabilities | 23 | 56 | 71 | 15 | 45 | 115 | 53 | 128 | 112 | 288 | 114 | 272 |
Total Liabilities | 35 | 70 | 118 | 60 | 98 | 159 | 138 | 341 | 381 | 752 | 748 | 1,681 |
Fixed Assets | 17 | 16 | 15 | 15 | 14 | 15 | 22 | 87 | 85 | 147 | 144 | 199 |
CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 9 | 6 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 74 | 74 | 74 | 81 | 114 |
Other Assets | 17 | 54 | 103 | 45 | 83 | 143 | 116 | 181 | 222 | 528 | 514 | 1,362 |
Total Assets | 35 | 70 | 118 | 60 | 98 | 159 | 138 | 341 | 381 | 752 | 748 | 1,681 |
Below is a detailed analysis of the balance sheet data for Refex Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 23.00 Cr. (Mar 2024) to 26.00 Cr., marking an increase of 3.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,224.00 Cr.. The value appears strong and on an upward trend. It has increased from 450.00 Cr. (Mar 2024) to 1,224.00 Cr., marking an increase of 774.00 Cr..
- For Borrowings, as of Mar 2025, the value is 158.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 161.00 Cr. (Mar 2024) to 158.00 Cr., marking a decrease of 3.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 272.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 114.00 Cr. (Mar 2024) to 272.00 Cr., marking an increase of 158.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,681.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 748.00 Cr. (Mar 2024) to 1,681.00 Cr., marking an increase of 933.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 199.00 Cr.. The value appears strong and on an upward trend. It has increased from 144.00 Cr. (Mar 2024) to 199.00 Cr., marking an increase of 55.00 Cr..
- For CWIP, as of Mar 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Mar 2024) to 6.00 Cr., marking a decrease of 3.00 Cr..
- For Investments, as of Mar 2025, the value is 114.00 Cr.. The value appears strong and on an upward trend. It has increased from 81.00 Cr. (Mar 2024) to 114.00 Cr., marking an increase of 33.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,362.00 Cr.. The value appears strong and on an upward trend. It has increased from 514.00 Cr. (Mar 2024) to 1,362.00 Cr., marking an increase of 848.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,681.00 Cr.. The value appears strong and on an upward trend. It has increased from 748.00 Cr. (Mar 2024) to 1,681.00 Cr., marking an increase of 933.00 Cr..
Notably, the Reserves (1,224.00 Cr.) exceed the Borrowings (158.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -9.00 | -3.00 | -34.00 | -33.00 | -39.00 | 28.00 | 42.00 | -6.00 | -24.00 | 26.00 | -12.00 | 58.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 65 | 215 | 376 | 87 | 173 | 69 | 40 | 54 | 96 | 55 | 81 | 101 |
Inventory Days | 174 | 4 | 7 | 22 | 33 | 7 | 2 | 4 | 8 | 3 | 3 | 2 |
Days Payable | 321 | 281 | 382 | 156 | 264 | 92 | 27 | 70 | 79 | 49 | 21 | 37 |
Cash Conversion Cycle | -82 | -63 | 1 | -47 | -57 | -15 | 15 | -12 | 24 | 8 | 63 | 66 |
Working Capital Days | -273 | -34 | -40 | 255 | 159 | 9 | 20 | 14 | 70 | 41 | 74 | 99 |
ROCE % | 15% | 24% | 6% | 7% | 6% | 61% | 85% | 45% | 25% | 48% | 29% | 25% |
This stock is not held by any mutual fund.
Key Financial Ratios
Month | Mar 25 | Mar 24 | Mar 23 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 2.00 | 2.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 12.93 | 8.40 | 53.89 | 21.73 | 21.37 |
Diluted EPS (Rs.) | 12.38 | 8.36 | 53.84 | 21.73 | 21.37 |
Cash EPS (Rs.) | 14.78 | 9.21 | 55.62 | 22.01 | 22.31 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 81.93 | 40.25 | 142.21 | 66.45 | 48.98 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 81.93 | 40.25 | 142.21 | 66.45 | 48.98 |
Revenue From Operations / Share (Rs.) | 191.02 | 119.54 | 736.94 | 301.24 | 426.97 |
PBDIT / Share (Rs.) | 20.14 | 14.21 | 82.75 | 34.34 | 36.27 |
PBIT / Share (Rs.) | 17.62 | 13.04 | 79.63 | 31.82 | 35.37 |
PBT / Share (Rs.) | 15.48 | 10.49 | 70.74 | 27.55 | 31.03 |
Net Profit / Share (Rs.) | 12.26 | 8.04 | 52.50 | 19.49 | 21.41 |
NP After MI And SOA / Share (Rs.) | 12.29 | 8.11 | 52.50 | 19.49 | 21.41 |
PBDIT Margin (%) | 10.54 | 11.88 | 11.22 | 11.39 | 8.49 |
PBIT Margin (%) | 9.22 | 10.90 | 10.80 | 10.56 | 8.28 |
PBT Margin (%) | 8.10 | 8.77 | 9.59 | 9.14 | 7.26 |
Net Profit Margin (%) | 6.41 | 6.72 | 7.12 | 6.47 | 5.01 |
NP After MI And SOA Margin (%) | 6.43 | 6.78 | 7.12 | 6.47 | 5.01 |
Return on Networth / Equity (%) | 15.00 | 20.16 | 36.91 | 29.33 | 43.70 |
Return on Capital Employeed (%) | 16.22 | 24.96 | 41.88 | 31.47 | 61.36 |
Return On Assets (%) | 8.82 | 11.76 | 15.42 | 11.99 | 24.01 |
Long Term Debt / Equity (X) | 0.08 | 0.11 | 0.12 | 0.00 | 0.00 |
Total Debt / Equity (X) | 0.16 | 0.25 | 0.26 | 0.00 | 0.02 |
Asset Turnover Ratio (%) | 1.90 | 1.78 | 0.00 | 2.64 | 4.46 |
Current Ratio (X) | 3.49 | 2.59 | 1.59 | 1.32 | 2.24 |
Quick Ratio (X) | 3.47 | 2.55 | 1.55 | 1.28 | 2.18 |
Inventory Turnover Ratio (X) | 74.24 | 30.57 | 0.00 | 47.60 | 80.69 |
Dividend Payout Ratio (NP) (%) | 0.00 | 5.88 | 0.00 | 5.13 | 0.00 |
Dividend Payout Ratio (CP) (%) | 0.00 | 5.14 | 0.00 | 4.54 | 0.00 |
Earning Retention Ratio (%) | 0.00 | 94.12 | 0.00 | 94.87 | 0.00 |
Cash Earning Retention Ratio (%) | 0.00 | 94.86 | 0.00 | 95.46 | 0.00 |
Interest Coverage Ratio (X) | 9.39 | 5.60 | 9.42 | 8.04 | 61.97 |
Interest Coverage Ratio (Post Tax) (X) | 6.72 | 4.17 | 6.99 | 5.56 | 43.99 |
Enterprise Value (Cr.) | 4698.88 | 1642.00 | 596.42 | 180.07 | 32.99 |
EV / Net Operating Revenue (X) | 1.90 | 1.19 | 0.36 | 0.28 | 0.04 |
EV / EBITDA (X) | 18.06 | 9.99 | 3.26 | 2.50 | 0.58 |
MarketCap / Net Operating Revenue (X) | 1.98 | 1.13 | 0.32 | 0.31 | 0.07 |
Retention Ratios (%) | 0.00 | 94.11 | 0.00 | 94.86 | 0.00 |
Price / BV (X) | 4.61 | 3.35 | 1.67 | 1.41 | 0.68 |
Price / Net Operating Revenue (X) | 1.98 | 1.13 | 0.32 | 0.31 | 0.07 |
EarningsYield | 0.03 | 0.06 | 0.22 | 0.20 | 0.63 |
After reviewing the key financial ratios for Refex Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.93. This value is within the healthy range. It has increased from 8.40 (Mar 24) to 12.93, marking an increase of 4.53.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.38. This value is within the healthy range. It has increased from 8.36 (Mar 24) to 12.38, marking an increase of 4.02.
- For Cash EPS (Rs.), as of Mar 25, the value is 14.78. This value is within the healthy range. It has increased from 9.21 (Mar 24) to 14.78, marking an increase of 5.57.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 81.93. It has increased from 40.25 (Mar 24) to 81.93, marking an increase of 41.68.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 81.93. It has increased from 40.25 (Mar 24) to 81.93, marking an increase of 41.68.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 191.02. It has increased from 119.54 (Mar 24) to 191.02, marking an increase of 71.48.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 20.14. This value is within the healthy range. It has increased from 14.21 (Mar 24) to 20.14, marking an increase of 5.93.
- For PBIT / Share (Rs.), as of Mar 25, the value is 17.62. This value is within the healthy range. It has increased from 13.04 (Mar 24) to 17.62, marking an increase of 4.58.
- For PBT / Share (Rs.), as of Mar 25, the value is 15.48. This value is within the healthy range. It has increased from 10.49 (Mar 24) to 15.48, marking an increase of 4.99.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.26. This value is within the healthy range. It has increased from 8.04 (Mar 24) to 12.26, marking an increase of 4.22.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 12.29. This value is within the healthy range. It has increased from 8.11 (Mar 24) to 12.29, marking an increase of 4.18.
- For PBDIT Margin (%), as of Mar 25, the value is 10.54. This value is within the healthy range. It has decreased from 11.88 (Mar 24) to 10.54, marking a decrease of 1.34.
- For PBIT Margin (%), as of Mar 25, the value is 9.22. This value is below the healthy minimum of 10. It has decreased from 10.90 (Mar 24) to 9.22, marking a decrease of 1.68.
- For PBT Margin (%), as of Mar 25, the value is 8.10. This value is below the healthy minimum of 10. It has decreased from 8.77 (Mar 24) to 8.10, marking a decrease of 0.67.
- For Net Profit Margin (%), as of Mar 25, the value is 6.41. This value is within the healthy range. It has decreased from 6.72 (Mar 24) to 6.41, marking a decrease of 0.31.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.43. This value is below the healthy minimum of 8. It has decreased from 6.78 (Mar 24) to 6.43, marking a decrease of 0.35.
- For Return on Networth / Equity (%), as of Mar 25, the value is 15.00. This value is within the healthy range. It has decreased from 20.16 (Mar 24) to 15.00, marking a decrease of 5.16.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.22. This value is within the healthy range. It has decreased from 24.96 (Mar 24) to 16.22, marking a decrease of 8.74.
- For Return On Assets (%), as of Mar 25, the value is 8.82. This value is within the healthy range. It has decreased from 11.76 (Mar 24) to 8.82, marking a decrease of 2.94.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.11 (Mar 24) to 0.08, marking a decrease of 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.16. This value is within the healthy range. It has decreased from 0.25 (Mar 24) to 0.16, marking a decrease of 0.09.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.90. It has increased from 1.78 (Mar 24) to 1.90, marking an increase of 0.12.
- For Current Ratio (X), as of Mar 25, the value is 3.49. This value exceeds the healthy maximum of 3. It has increased from 2.59 (Mar 24) to 3.49, marking an increase of 0.90.
- For Quick Ratio (X), as of Mar 25, the value is 3.47. This value exceeds the healthy maximum of 2. It has increased from 2.55 (Mar 24) to 3.47, marking an increase of 0.92.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 74.24. This value exceeds the healthy maximum of 8. It has increased from 30.57 (Mar 24) to 74.24, marking an increase of 43.67.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 5.88 (Mar 24) to 0.00, marking a decrease of 5.88.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 5.14 (Mar 24) to 0.00, marking a decrease of 5.14.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 94.12 (Mar 24) to 0.00, marking a decrease of 94.12.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 94.86 (Mar 24) to 0.00, marking a decrease of 94.86.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 9.39. This value is within the healthy range. It has increased from 5.60 (Mar 24) to 9.39, marking an increase of 3.79.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.72. This value is within the healthy range. It has increased from 4.17 (Mar 24) to 6.72, marking an increase of 2.55.
- For Enterprise Value (Cr.), as of Mar 25, the value is 4,698.88. It has increased from 1,642.00 (Mar 24) to 4,698.88, marking an increase of 3,056.88.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has increased from 1.19 (Mar 24) to 1.90, marking an increase of 0.71.
- For EV / EBITDA (X), as of Mar 25, the value is 18.06. This value exceeds the healthy maximum of 15. It has increased from 9.99 (Mar 24) to 18.06, marking an increase of 8.07.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.98. This value is within the healthy range. It has increased from 1.13 (Mar 24) to 1.98, marking an increase of 0.85.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 94.11 (Mar 24) to 0.00, marking a decrease of 94.11.
- For Price / BV (X), as of Mar 25, the value is 4.61. This value exceeds the healthy maximum of 3. It has increased from 3.35 (Mar 24) to 4.61, marking an increase of 1.26.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.98. This value is within the healthy range. It has increased from 1.13 (Mar 24) to 1.98, marking an increase of 0.85.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.06 (Mar 24) to 0.03, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Refex Industries Ltd:
- Net Profit Margin: 6.41%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.22% (Industry Average ROCE: 14.87%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15% (Industry Average ROE: 13.35%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 6.72
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.47
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 25.4 (Industry average Stock P/E: 67.07)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.16
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.41%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Industrial Gases | 2nd Floor, Refex Towers, Sterling Road Signal, 313, Valluvar Kottam High Road, Chennai (Madras) Tamil Nadu 600034 | investor.relations@refex.co.in http://www.refex.co.in |
Management | |
---|---|
Name | Position Held |
Mr. Anil Jain | Chairman & Managing Director |
Mr. Dinesh Kumar Agarwal | WholeTime Director & CFO |
Ms. Susmitha Siripurapu | Non Executive Director |
Mr. Ramesh Dugar | Independent Director |
Mr. Sivaramakrishnan Vasudevan | Independent Director |
Ms. Latha Venkatesh | Independent Director |
Dr. Vineet Kothari | Independent Director |
FAQ
What is the intrinsic value of Refex Industries Ltd?
Refex Industries Ltd's intrinsic value (as of 20 October 2025) is 433.34 which is 24.88% higher the current market price of 347.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 4,751 Cr. market cap, FY2025-2026 high/low of 575/334, reserves of ₹1,224 Cr, and liabilities of 1,681 Cr.
What is the Market Cap of Refex Industries Ltd?
The Market Cap of Refex Industries Ltd is 4,751 Cr..
What is the current Stock Price of Refex Industries Ltd as on 20 October 2025?
The current stock price of Refex Industries Ltd as on 20 October 2025 is 347.
What is the High / Low of Refex Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Refex Industries Ltd stocks is 575/334.
What is the Stock P/E of Refex Industries Ltd?
The Stock P/E of Refex Industries Ltd is 25.4.
What is the Book Value of Refex Industries Ltd?
The Book Value of Refex Industries Ltd is 96.8.
What is the Dividend Yield of Refex Industries Ltd?
The Dividend Yield of Refex Industries Ltd is 0.14 %.
What is the ROCE of Refex Industries Ltd?
The ROCE of Refex Industries Ltd is 25.3 %.
What is the ROE of Refex Industries Ltd?
The ROE of Refex Industries Ltd is 22.0 %.
What is the Face Value of Refex Industries Ltd?
The Face Value of Refex Industries Ltd is 2.00.